УДК 618:619 DOI 10.33861/2071-8020-2024-2-30-31 Chekrysheva V.V. Summary. Data on the study of dyshormonal mammary dysplasia in dogs are presented in the article. The comparative description of Mastofit ‘Evalar’ and Mastodinon use was carried out for three-month-research. The first experimental group of animals was prescribed Mastofit ‘Evalar’ 2.5 mg orally three times per day for 3 months. Mastodinon was used (% tablet twice per day for 3 months) in the second experimental group of dogs. The efficiency of complex homeopathic preparations was compared using control measurements of the size of the pathological focus at the end of the therapy period. As a result of the experiment, it was found that the use of complex homeopathic preparations, such as Mastofit ‘Evalar’ and Mastodinon, has a positive effect on the growth of the pathological lesion in dyshormonal dysplasia of the mammary gland in dogs, stopping the growth and development of pathology. The use of these preparations in the dosages recommended by the manufacturer for 3 months significantly stops the growth and development of dyshormonal mammary dysplasia in dogs. Keywords: mammary gland, milk lobules, mammary dysplasia, benign mammary dysplasia, mastopathy, carnivores, animals, dogs, mastopathy therapy, treatment. References: 1. Avdeenko V. S., Pustinin D. A., Rykhlov A. S. Verifikatsiya diagnoza i terapiya mastopatii u sobak [Verification of diagnosis and therapy of mastopathy in dogs]. - 2014: 142-145. 2. Pustotin D. A. et al. Diagnostika i terapiya mastopatii u sobak [Diagnosis and therapy of mastopathy in dogs]. - 2014: 35-38. 3. Ishenbaeva S. N., Irgashev A. Sh. Fibrozno-kistoznaya mastopatiya u sobak [Fibrocystic mastopathy in dogs]. - 2019: 90-94. 4. Pustotin D. A. Verifikatsiya diagnoza i terapiya disgormonalnoy mastopatii u sobak [Verification of diagnosis and therapy of dyshormonal mastopathy in dogs]. - 2018. 5. Avdeenko V. S. et al. Rentgeno-ekhograficheskoe obosnovanie primeneniya preparata «Tamoksifen» pri mastopatii u sobak [X-ray echographic substantiation of the Tamoxifen use for mastopathy in dogs]. -2012: 206-210. Author affiliation: Chekrysheva Viktoriya V., D. Sc. in Veterinary Medicine, Director of the North Caucasian Zonal Research Veterinary Institute - branch of the Federal Rostov Agrarian Scientific Center; 0, Rostov hgw., Novocherkassk, Rostov region, Russia, 346421; phone: 8-908-5110139; e-mail: veterinar1987@mail.ru.
|